Drugs for Non-small Cell Lung Cancer Market Analysis, Size, Share, and Forecast 2031
The Drugs for Non-small Cell Lung Cancer Market in 2023 is US$ 18.35 billion, and is expected to reach US$ 37.92 billion by 2031 at a CAGR of 9.50%.
The Drugs for Non-small Cell Lung Cancer Market in 2023 is US$ 18.35 billion, and is expected to reach US$ 37.92 billion by 2031 at a CAGR of 9.50%.